Assyro AI

FDA Orange Book · active-ingredient family

Technetium tc-99m exametazime kit

Technetium tc-99m exametazime kit is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:CERETEC · NDA 019829

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, powder

ProductApplicantApplicationTEApproved
CERETECRLDGE HEALTHCARENDA 019829Dec 30, 1988
DRAX EXAMETAZIMEJUBILANTNDA 208870Aug 17, 2017

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Technetium tc-99m exametazime kit — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.